-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DocGo, Inc. (DCGO)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against DocGo, Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO). The investigation concerns whether DocGo and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

DocGo, Inc. operates as a health care distribution company. The Company offers mobile health services and integrated medical mobility solutions.

On July 30, 2023, the New York Times published an article reporting a “rocky” start to DocGo’s migrant relocation efforts in New York City. The New York Times article reported that asylum-seekers have complained of threats and “broken promises” after New York City awarded DocGo a no-bid $432 million contract in May to move migrants outside the city. On this news, the price of DocGo shares declined by $0.36 per share, or approximately 4.11%, from $8.75 per share to close at $8.39 on July 31, 2023.

On September 6, 2023, the New York City Comptroller announced that it rejected the $432 million contract with DocGo, citing that “there was little evidence to show” that the Company had the experience and fiscal capacity to provide the migrant relocation services it had been contracted for. On this news, the price of DocGo shares declined by $0.61 per share, or approximately 7.48%, from $8.16 per share to close at $7.55 on September 6, 2023.

Then, on September 15, 2023, DocGo Chief Executive Officer, Anthony Capone, resigned for personal reasons. Capone’s resignation came shortly after Capone confirmed that he does not have a graduate degree in computational learning despite previously claiming that he did in his official biography on DocGo’s website, in filings with the U.S. Securities and Exchange Commission, and to the Albany Times Union. On this news, the price of DocGo shares declined by $0.76 per share, or approximately 11.76%, from $6.46 per share to close at $5.70 on September 15, 2023.

If you purchased or otherwise acquired DocGo securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:DCGO

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

KD INVESTOR REMINDER: Kyndryl Holdings, Inc. Investors Have Until April 13, 2026 to Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:KD) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 13, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline...

GEMI INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Gemini Space Station, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ:GEMI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On September 12, 2025, Gemini conducted its initial public offering, selling 15,937,501 shares of Class A co...

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 13, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The...
Back to Newsroom